Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer

计划入组 42 人 · 首次发布于 2008 年 6 月 24 日

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

计划入组 36 人 · 首次发布于 2022 年 1 月 13 日

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

计划入组 117 人 · 首次发布于 2006 年 12 月 19 日

Ab1120-vcMMAE

HB22.7-vcMMAE

huPr1-vcMMAE

Center 5

United States

PB ADMINISTRADORA DE ESTACIONAMENTOS LTDA

Brazil

Hangzhou MTR Line 5 Corporation Limited

China

Precision Biologics Reports Promising Efficacy Data for Novel Ovarian Cancer ADC PB-vcMMAE-5

Precision Biologics Presents Preclinical Data on Novel PB-223 ADC Targeting Truncated Core-2 Glycans in Solid Tumors

Eirion Therapeutics' ET-02 Shows Promise in Phase 1 Trial for Androgenic Alopecia